Nancy A Dreyer
Impact in
- Statistics and Probability top 1%
- Statistical Methods in Clinical Trials
- Advanced Causal Inference Techniques
- Economics and Econometrics top 1%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
Papers in
-
- Statistical Methods in Clinical Trials 25
- Advanced Causal Inference Techniques 13
-
- Health Systems, Economic Evaluations, Quality of Life 40
- Healthcare Policy and Management 7
- Co-authors
- Priscilla VelentgasRichard E GliklichKenneth J. RothmanAlexander M. WalkerMarc L. BergerJeanne LoughlinParivash NourjahScott R. Smith
- Journals
- Pharmacoepidemiology and Drug Safety (14 papers)Therapeutic Innovation & Regulatory Science (9 papers)Epidemiology (8 papers)Clinical Pharmacology & Therapeutics (6 papers)Value in Health (3 papers)
- Partner nations
- United StatesUnited KingdomPakistan
In The Last Decade
Nancy A Dreyer
127 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 182
- Statistics and Probability 453
- Economics and Econometrics 813
- Biophysics 164
- Statistics, Probability and Uncertainty 171
- Toxicology 68
Countries citing papers authored by Nancy A Dreyer
This map shows the geographic impact of Nancy A Dreyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy A Dreyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy A Dreyer more than expected).
Fields of papers citing papers by Nancy A Dreyer
This network shows the impact of papers produced by Nancy A Dreyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy A Dreyer. The network helps show where Nancy A Dreyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy A Dreyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2020 | 9 | |
| 8 | 2020 | 14 | |
| 9 | 2019 | 24 | |
| 10 | 2019 | 5 | |
| 11 | 2018 | 29 | |
| 12 | 2018 | 63 | |
| 13 | 2016 | 1 | |
| 14 | 2016 | 0 | |
| 15 | 2016 | 4 | |
| 16 | 2015 | 11 | |
| 17 | 2014 | 9 | |
| 18 | 5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis. | 1997 | 31 |
| 19 | 1996 | 11 | |
| 20 | An Epidemiologic View of Causation: How It Differs from the Legal | 1994 | 0 |
About Nancy A Dreyer
Nancy A Dreyer is a scholar working on Statistics and Probability, Economics and Econometrics, Statistics, Probability and Uncertainty, Toxicology and Health Informatics, having authored 135 papers that have together received 3.6k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (40 papers), Statistical Methods in Clinical Trials (25 papers), Advanced Causal Inference Techniques (13 papers), Meta-analysis and systematic reviews (10 papers), Ethics in Clinical Research (8 papers), Influenza Virus Research Studies (8 papers), COVID-19 Clinical Research Studies (8 papers) and Healthcare Policy and Management (7 papers). The work is most often cited by research in Statistics and Probability (453 citations), Economics and Econometrics (813 citations), Biophysics (164 citations), Statistics, Probability and Uncertainty (171 citations) and Toxicology (68 citations). Nancy A Dreyer has collaborated with scholars based in United States, United Kingdom and Pakistan. Frequent co-authors include Priscilla Velentgas, Richard E Gliklich, Kenneth J. Rothman, Alexander M. Walker, Marc L. Berger, Jeanne Loughlin, Parivash Nourjah, Scott R. Smith, Stephan Lanes and Michelle B Leavy. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, Therapeutic Innovation & Regulatory Science, Epidemiology, Clinical Pharmacology & Therapeutics and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.